Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06688500 · ClinicalTrials.gov registry record
Bowel Dysfunction and HoLEP Outcomes
A clinical trial of Urologic Injuries, sponsored by Northwestern University.
- Recruiting
- Registry status
- 126
- Enrollment target
- 1
- Study location
NCT06688500: Recruiting study of Urologic Injuries, sponsored by Northwestern University.
NCT06688500 is a study of Urologic Injuries that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 126 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06688500, a study of Urologic Injuries, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this prospective study is to examine the correlation and effects of bowel dysfunction on outcomes for patients undergoing holmium laser enucleation of prostate (HoLEP) for lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH).The investigator hypothesizes that patients who have more bowel dysfunction based on higher severity scores on patient-reported validated questionnaires will experience more symptoms in the immediate post-operative period and may have slower recovery of urinary control. Assessment of pre, peri, and post-procedural bowel dysfunction via the Constipation Severity Score (CSS) and Vaizey Incontinence Questionnaire will aid the analysis.
Primary Outcome
Identifying differences in AUASS scores pre-operatively versus post-operatively. An AUA symptom score of 0-7 is considered mild, 8-19 is moderate, and 20-35 is severe. This will be used in combination with the other measures to come up with total severity of overall condition.
Conditions Studied
Interventions
- PROCEDURE Bowel function post Holmium Laser Enucleation of the Prostate
Study Locations (1)
Illinois
- Northwestern Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2025-10-31 |
What NCT06688500 shows while recruiting
NCT06688500 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Urologic Injuries appearing as the primary indexed condition, and to 1 intervention - of which Bowel function post Holmium Laser Enucleation of the Prostate is the first listed.
NCT06688500 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06688500 about?
NCT06688500 is a clinical study titled "Bowel Dysfunction and HoLEP Outcomes". The objective of this prospective study is to examine the correlation and effects of bowel dysfunction on outcomes for patients undergoing holmium laser enucleation of prostate (HoLEP) for lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH).The investigator hypothesizes that...
What is the current status of trial NCT06688500?
This trial is currently recruiting. The enrollment target is 126 participants. The study started on 2023-10-05. Estimated completion is 2025-10-31.
What conditions does trial NCT06688500 study?
This clinical trial studies the following conditions: Urologic Injuries.
What interventions are being tested in trial NCT06688500?
The interventions under investigation include: Bowel function post Holmium Laser Enucleation of the Prostate (PROCEDURE).
Who is sponsoring clinical trial NCT06688500?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06688500 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI